Jiayan Yan

Jiayan Yan

Auto-generated profile, based on publicly available information

Jiayan Yan

Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
JYJ Yan
J Yan
HFH Feng
H Feng
HWH Wang
H Wang
FYF Yuan
F Yuan
CYC Yang
C Yang
JWJian Wang
Jian Wang
Background: Precise classification of the hepatic artery is helpful for preoperative surgical planning in hepatobiliary–pancreatic surgery. However, the anatomy of hepatic arteries is variable. This study investigated anatomical variation using three-dimensional visualization and evaluation (3DVE) to develop a nomenclature system. Methods: The origin and course of the hepatic artery were tracked and analysed by using three-dimensional visualization of CT images acquired between 2013 and 2017. The new classification and nomenclature system, named CRL, was developed based on the origins of the common, right and left hepatic arteries. Results: Scans from 770 adults were evaluated. Preoperative 3DVE correlated better with surgical findings than the original CT images alone. Using the CRL classification system, hepatic arteries were divided into nine subtypes. Only 87·4–89·2 per cent of the hepatic arteries of 610 living-donor liver transplant donors were depicted in Michels', Hiatt's or Varotti's classification, compared with 100 per cent identified by the CRL classification. The CRL classification was validated against external data sets from previous studies, with 99·6–100·0 per cent of patients classified by the CRL system. Conclusion: The CRL classification covers hepatic artery variants and may be used for planning liver surgery.

14 January 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
HFHao Feng
Hao Feng
HTHuan Tong
Huan Tong
JYJiayan Yan
Jiayan Yan
MHMin He
Min He
WCWei Chen
Wei Chen
JWJian Wang
Jian Wang
Adolescents and young adults (AYAs) diagnosed with cancer between ages 15~45 years may exhibit unique biologic and genomic characteristics as well as clinical features, resulting in differences in clinical characters and drug resistance. However, compared to other solid cancers, relatively few studies have been conducted in this age group in cholangiocarcinoma (CCA). This study is to investigate the clinical and molecular features of AYAs with CCA. Three cohorts, including the external dataset (TCGA and MSKCC) and the perihilar CCA databank of Chinese tertiary hospitals, were contained in this study. Pathway and process enrichment analysis had been carried out with the following ontology sources: KEGG Pathway, GO Biological Processes, Reactome Gene Sets, Canonical Pathways, and CORUM. Metascape and GEPIA datasets were used for bioinformatic analysis. P< 0.05 was considered statistically significant. All statistical analyses were performed with GraphPad Prism (version 7.0; GraphPad Software, La Jolla, California) and R studio (version 3.6.1; R studio, Boston, Massachusetts). Compared to older adults, AYAs with CCA presented with worse overall survival, though the difference was not significant. Specific to patients with stage IV CCAs who underwent chemotherapy, AYAs were associated with significantly poorer OS (Fig.1B. p=0.03, HR 3.01, 95%CI 1.14~4.91). From the anatomical perspective, more eCCA was detected in the AYA group. MSI occurred in 3% of older patients in the present study. Nevertheless, none of the AYAs had MSI status. Here in this study, AYAs gained an enhanced frequency of ASXL1(p=0.02) and KMT2C(p=0.02) mutation than their older counterparts. Besides ASXL and KMT2C, the genes enriched in AYAs with CCA were analyzed by pathway and process enrichment analysis. And those genes were found to be associated with poorer differentiation, deubiquitination, and WNT signal pathway. Moreover, AYAs were relevant to poor differentiation and advanced tumor stage. This study offered a preliminary landscape of the clinical and molecular features of early onset biliary cancers. Further studies including more samples are essential to investigate whether ASXL1 and KMT2C could be considered as potentially targetable genomic signatures for young patients.

13 December 2025 in Gut
Verified
Journal Article
Open access
JYJiayan Yan
Jiayan Yan
AHAo Huang
Ao Huang
SZShiyu Zhang
Shiyu Zhang
NYNa Yao
Na Yao
JHJunfeng Huang
Junfeng Huang
ZJZhou Jian
Zhou Jian
Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) effectively induces rapid liver hypertrophy in patients with initially unresectable liver tumours, yet the immunological mechanisms remain unclear. Objective: We aim to elucidate the immune alterations and underlying mechanisms driving liver regeneration following ALPPS. Design: The cohort study included single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics on remnant liver tissues from ALPPS patients. Neutrophil infiltration was validated by flow cytometry and histological analyses in the world’s largest ALPPS clinical cohort and mouse ALPPS models. Functional validation, including neutrophil depletion, matrix metalloproteinase 9 (MMP9) inhibition and CD177 blockade, as well as Cd177 knockout and CD177 + neutrophil infusion in vivo. Results: scRNA-seq revealed substantial neutrophil infiltration following stage 1 ALPPS. Depletion of neutrophils impaired liver regeneration. Among subsets, CD177 + neutrophils were metabolically active with enhanced neutrophil extracellular traps formation and secreted MMP9. MMP9 inhibition disrupted extracellular matrix (ECM) degradation and hepatocyte growth factor alpha (HGF-α) release, impairing regeneration. CD177 + neutrophils interacted with endothelial cells via CD177–PECAM1 to facilitate transmigration, while hepatic stellate cell-derived CXCL8 promoted neutrophil chemotaxis via CXCL8–CXCR1/2. Cd177 deficiency attenuated neutrophil infiltration and regenerative growth, while CD177 + neutrophil infusion restored regeneration, which was abolished in Cd177 − / − mice. Conclusions: CD177 + neutrophils drive liver regeneration by promoting endothelial transmigration, ECM degradation and HGF-α release. These findings reveal a neutrophil-mediated mechanism driving surgical liver regeneration and support the potential of CD177 + neutrophil infusion to establish a proregenerative hepatic environment for therapeutic strategies in liver failure.

9 February 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
JYJiayan Yan
Jiayan Yan
ZJZhifeng Jiang
Zhifeng Jiang
SZShiyu Zhang
Shiyu Zhang
QYQichao Yu
Qichao Yu
YLYijun Lu
Yijun Lu
XYXin-Rong Yang
Xin-Rong Yang
Solid tumours are intricate and highly heterogeneous ecosystems, which grow in and invade normal organs. Their progression is mediated by cancer cells’ interaction with different cell types, such as immune cells, stromal cells and endothelial cells, and with the extracellular matrix. Owing to its high incidence, aggressive growth and resistance to local and systemic treatments, liver cancer has particularly high mortality rates worldwide. In recent decades, spatial heterogeneity has garnered significant attention as an unfavourable biological characteristic of the tumour microenvironment, prompting extensive research into its role in liver tumour development. Advances in spatial omics have facilitated the detailed spatial analysis of cell types, states and cell‒cell interactions, allowing a thorough understanding of the spatial and temporal heterogeneities of tumour microenvironment and informing the development of novel therapeutic approaches. This review illustrates the latest discovery of the invasive zone, and systematically introduced specific macroscopic spatial heterogeneities, pathological spatial heterogeneities and tumour microenvironment heterogeneities of liver cancer.

22 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
LWLiang Wu
Liang Wu
JYJiayan Yan
Jiayan Yan
YBYinqi Bai
Yinqi Bai
FCFeiyu Chen
Feiyu Chen
JXJiangShan Xu
JiangShan Xu
ZJZhou Jian
Zhou Jian
Solid tumors are complex ecosystems, and heterogeneity is the major challenge for overcoming tumor relapse and metastasis. Uncovering the spatial heterogeneity of cell types and functional states in tumors is essential for developing effective treatment, especially in invasive fronts of tumor, the most active region for tumor cells infiltration and invasion. We firstly used SpaTial Enhanced REsolution Omics-sequencing (Stereo-seq) with a nanoscale resolution to characterize the tumor microenvironment of intrahepatic cholangiocarcinoma (ICC). Enrichment of distinctive immune cells, suppressive immune microenvironment and metabolic reprogramming of tumor cells were identified in the 500µm-wide zone centered bilaterally on the tumor boundary, namely invasive fronts of tumor. Furthermore, we found the damaged states of hepatocytes with overexpression of Serum Amyloid A (SAA) in invasive fronts, recruiting macrophages for facilitating further tumor invasion, and thus resulting in a worse prognosis. We also confirmed these findings in hepatocellular carcinoma and other liver metastatic cancers. Our work highlights the remarkable potential of high-resolution-spatially resolved transcriptomic approaches to provide meaningful biological insights for comprehensively dissecting the tumor ecosystem and guiding the development of novel therapeutic strategies for solid tumors.